NCT00230633View on ClinicalTrials.gov

Studies of White Blood Cells Derived From HHT Patients

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Telangiectasia, Hereditary Hemorrhagic
Trial Locations (1)

W12 0NN

Imperial College Hammersmith Campus, London

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

lead

Imperial College London

OTHER

NCT00230633 - Studies of White Blood Cells Derived From HHT Patients | Biotech Hunter | Biotech Hunter